Dr Anguraj Sadnandam talks about his research that divided bowel cancer up into four distinct diseases, each with its own set of biological characteristics.
Dr Nick Turner, from the ICR and The Royal Marsden, talks to Claire about a blood test for breast cancer that can identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Professor Andrew Tutt speaks about the LEGACY study – which will help us to understand the underlying biology of secondary breast cancer.
Professor Mel Greaves explains how some cancers that appear to have been cured can recur many years or even decades later.
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours.
A landmark study for the ICR's Professor Johann de Bono hails the new era of personalised treatment for prostate cancers that have spread round the body.
Despite huge variety between prostate tumours and metastases in individual men, they also share common gene faults – an insight that could offer new treatments.
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – a finding that could open up exciting new approaches to treatment.
A blood test that measures the number of cells shed from prostate tumours into the bloodstream can act as an early warning sign that treatment is not working.